BioSpace News Archive

Vyripharm Biopharmaceuticals, a subsidiary of Vyripharm Enterprises, LLC, a privately held company located in the Texas Medical Center in Houston, Texas, announced today that it has signed off on a Master Drug Program Agreement with Regis Technologies, Inc. Regis is a privately held contract development manufacturing organization (CDMO) in Morton Grove, Illinois.

Medicure Inc. (“Medicure” or the “Company”) (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, is pleased to announce that on Saturday, June 27, 2020, Dr. Marco Valgimigli, MD, PhD, Professor of Cardiology, Director of Clinical Research at Bern University Hospital, will present the results of the FABOLUS-FASTER Phase 4 clinical trial.

Demonstrated a eA1c reduction of 1.42% which was sustained for two years 71% of hypertension users demonstrated reductions in blood pressure averaging 8.1 mmHg systolic and 6.0 mmHg diastolic. Average ratio of high blood glucose events was reduced by 26% and sustained for one year

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that Vernalis Research, a Ligand company, has expanded its oncology research collaboration with Servier, an international pharmaceutical company based in France, to jointly identify and enable new therapeutic targets. The new three-year research collaboration combines Vernalis’ strengths in structure and biophysics-based methods as par

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that Scientific Advisory Board member and inventor of novel peptide COVID-19 therapeutic, Michael H. Peters , Ph.D., Professor, Department of Chemical and Life Science Engineering at VCU, College of Engineering, has published a white paper detailing his

MannKind Corporation (Nasdaq: MNKD) announced that new data from clinical studies of Afrezza® (insulin human) Inhalation Powder was presented at the American Diabetes Association’s 80th Scientific Sessions, June 12-16, 2020.

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell therapies for neurodegenerative diseases, announced that it has been granted Small and Medium-Sized Enterprise status by the European Medicines Agency’s Micro, Small and Medium-Sized Enterprise office.

Longhorn Vaccines & Diagnostics, an innovative molecular tool, assay and vaccine development company, and Pharmco, Greenfield Global’s popular brand of specialty al

A new nonsurgical treatment decreases errant blood flow in the shoulder to quickly reduce pain and improve function in patients with adhesive capsulitis, also known as “frozen shoulder,” according to research presented during a virtual session of the Society of Interventional Radiology’s 2020 Annual Scientific Meeting on June 13.

Data from one of the first clinical uses of augmented reality guidance with electromagnetically tracked tools shows that the technology can help doctors quickly, safely, and accurately deliver targeted liver cancer treatments, according to research presented during a virtual session of the Society of Interventional Radiology’s 2020 Annual Scientific Meeting on June 14.